Viruses are vehicles which transmit biological information, reprogramming the function of human, animal or plant cells to produce progeny virions. Viral pathogens are very small, often with a very simple structure. Indeed, enveloped viruses are composed only of a protein shell filled with genetic material, surrounded by a lipid envelope decorated with viral proteins. Nevertheless, viral pathogens like HIV or the hepatitis C virus (HCV) threaten the health of many millions of individuals. Important human pathogens among the group of RNA viruses include besides HCV alsothe respiratory syncytial virus (RSV) and Chikunguna virus (CHIKV).
The institute comprises two research groups that focus on hepatitis viruses (HCV, HEV), RSV and CHIKV.
Stepping stone to an academic career in Virology
On 23rd and 24th of March 2020 the second ACHIEVE Spring School of the Society for Virology (GfV) will take place in Berlin. This year's theme is "learning from each other - growing together" and the two days’ workshop will deals with the topic "professional development". We will have Experts talking about the behind the scenes of the path through an academic career, round table talks about shared experiences and tips from professionals: How do you write the perfect paper? What makes a good proposal, where can I obtain financial support? With regard to scientific content, we will deal with the highly topical issue of zoonoses, which always presents us with new challenges.
The programme is aimed at doctoral students from the fields of medicine, veterinary medicine or life sciences at the end of their doctoral studies and at postdoctoral fellows at the beginning of their careers. Places are limited to ensure optimal interaction between participants and guest speakers.
The participation of the students in the ACHIEVE Spring School is financed by a scholarship, which includes the costs for travel, accommodation and meals. An application requires membership to the Society for Virology and consists of a curriculum vitae, a letter of motivation (maximum one page) and a letter of recommendation from a faculty member. Applications are not possible any more.
The closing date for applications was February 20th, 2020.
Group leader Chris Lauber funded by RESIST
Fraunhofer Research consortium iCAIR® makes use of synergies to develop new medications against SARS-CoV-2
With its rapid spread around the world, the new coronavirus SARS-CoV-2 has triggered a public health emergency of international concern. To date, there is neither a vaccine nor drugs for treating COVID-19 patients available....
RESIST-Scientist Professor Pietschmann, head of the TWINCORE Insitute for Experimental Virology, leads the German part of an international consortium of scientists. This research network is searching for substances that act...
Activities concerning novel coronavirus have begun